Profile data is unavailable for this security.
About the company
RIBOMIC Inc. is engaged in the drug discovery business based on the platform Ribomic Aptamer Refined Therapeutics System related to aptamer drug discovery technology. Its drug discovery business is divided into self discovery and co-discovery divisions. Self Drug Discovery division develops aptamer and licenses and out the results to pharmaceutical companies. The Co-Discovery division earns the research expenses paid by the alliance partner for the shared part of co-discovery business with alliance pharmaceutical companies researching aptamer pharmaceutical.
- Revenue in JPY (TTM)0.00
- Net income in JPY-1.05bn
- Incorporated2003
- Employees25.00
- LocationRibomic Inc6F, Shirokanedai Usui Bldg.3-16-13, ShirokanedaiMINATO-KU 108-0071JapanJPN
- Phone+81 334403303
- Fax+81 334403729
- Websitehttps://www.ribomic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PhoenixBio Co Ltd | 1.51bn | -311.88m | 1.95bn | 69.00 | -- | 1.41 | -- | 1.29 | -78.53 | -78.53 | 372.28 | 339.41 | 0.6513 | 0.9529 | 6.96 | 21,877,380.00 | -13.46 | -4.25 | -16.43 | -5.57 | 75.84 | 67.17 | -20.66 | -7.19 | 2.91 | -- | 0.2067 | -- | -10.14 | 3.29 | -1,801.92 | -- | 1.08 | -- |
| Kringle Pharma Inc | 72.22m | -916.26m | 2.81bn | 17.00 | -- | 2.05 | -- | 38.88 | -133.98 | -133.98 | 10.55 | 186.56 | 0.0299 | -- | 1.22 | 4,247,941.00 | -37.89 | -23.52 | -39.85 | -24.93 | -- | -- | -1,268.79 | -349.89 | 16.51 | -5,167.34 | 0.00 | -- | -9.77 | -31.17 | -21.13 | -- | -- | -- |
| Veritas In Silico Inc | 95.43m | -376.29m | 3.22bn | 19.00 | -- | 1.67 | -- | 33.72 | -58.00 | -58.00 | 14.71 | 296.60 | 0.0442 | -- | -- | 5,022,579.00 | -17.42 | -- | -17.81 | -- | -- | -- | -394.31 | -- | 31.68 | -- | 0.00 | -- | -45.99 | -- | -815.45 | -- | -- | -- |
| NPT Co Ltd | 0.00 | -266.47m | 3.41bn | 6.00 | -- | 43.82 | -- | -- | -54.98 | -54.98 | 0.00 | 15.98 | 0.00 | -- | -- | -- | -318.44 | -- | -439.04 | -- | -- | -- | -- | -- | -- | -2,152.88 | 0.00 | -- | -- | -- | -68.67 | -- | -- | -- |
| FunPep Co Ltd | 2.94m | -1.56bn | 4.10bn | 15.00 | -- | 1.92 | -- | 1,395.42 | -44.48 | -44.48 | 0.0815 | 52.71 | 0.001 | 0.0467 | -- | 195,733.30 | -51.62 | -28.60 | -60.65 | -30.40 | 39.68 | -- | -53,241.21 | -3,042.40 | 4.60 | -608.88 | 0.00 | -- | 1,056.04 | -54.12 | 4.75 | -- | -2.98 | -- |
| Human Metabolome Technologies Inc | 1.37bn | 194.67m | 4.16bn | 62.00 | 21.81 | 2.36 | 13.62 | 3.03 | 32.18 | 32.18 | 236.21 | 297.91 | 0.6395 | 8.69 | 8.86 | 22,148,600.00 | 9.07 | 10.54 | 11.01 | 13.59 | 61.42 | 66.65 | 14.18 | 17.24 | 4.81 | 230.20 | 0.0601 | 20.98 | 8.12 | 5.40 | 5.42 | -- | 33.68 | -- |
| Ribomic Inc | 0.00 | -1.05bn | 4.67bn | 25.00 | -- | 1.36 | -- | -- | -23.81 | -23.81 | 0.00 | 63.04 | 0.00 | -- | -- | 0.00 | -31.15 | -29.95 | -32.30 | -31.15 | -- | -- | -- | -2,725.95 | 25.20 | -- | 0.00 | -- | -- | -55.55 | 0.5173 | -- | -6.86 | -- |
| Modalis Therapeutics Corp | 0.00 | -2.06bn | 5.07bn | 14.00 | -- | 1.72 | -- | -- | -27.71 | -27.71 | 0.00 | 33.64 | 0.00 | -- | -- | 0.00 | -66.07 | -35.65 | -74.94 | -36.83 | -- | -- | -- | -1,981.18 | -- | -- | 0.0888 | -- | -- | -- | 44.90 | -- | -67.80 | -- |
| D.Western Therapeutics Institute Inc | 419.76m | -1.06bn | 5.53bn | 21.00 | -- | 3.70 | -- | 13.18 | -24.98 | -24.98 | 9.48 | 27.56 | 0.1921 | 0.4194 | 2.71 | 19,988,760.00 | -48.31 | -24.39 | -52.24 | -26.58 | 89.75 | 93.00 | -251.53 | -142.25 | 8.69 | -274.87 | 0.2606 | -- | 10.09 | -4.07 | -58.82 | -- | -- | -- |
| Carna Biosciences, Inc. | 579.06m | -2.17bn | 5.97bn | 63.00 | -- | 19.31 | -- | 10.32 | -113.62 | -113.62 | 30.30 | 16.16 | 0.2894 | 1.24 | 6.17 | -- | -108.53 | -37.21 | -120.28 | -41.98 | 67.03 | 86.49 | -375.00 | -118.28 | 6.08 | -75.55 | 0.6979 | -- | -8.99 | -12.57 | 0.3262 | -- | -33.02 | -- |
| TMS Co Ltd | 0.00 | -670.20m | 6.50bn | 18.00 | -- | 2.17 | -- | -- | -15.72 | -15.72 | 0.00 | 65.78 | 0.00 | -- | -- | 0.00 | -21.59 | -- | -22.41 | -- | -- | -- | -- | -- | 23.99 | -- | 0.00 | -- | -- | -- | 31.20 | -- | -- | -- |
| Cyfuse Biomedical KK | -100.00bn | -100.00bn | 6.75bn | 21.00 | -- | 2.27 | -- | -- | -- | -- | -- | 298.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.80 | -- | 0.3038 | -- | -10.91 | -- | -48.03 | -- | -- | -- |
| Noile-Immune Biotech Inc | 7.14m | -782.47m | 6.76bn | 25.00 | -- | 1.64 | -- | 945.69 | -18.07 | -18.07 | 0.165 | 95.16 | 0.0016 | 0.00 | 0.0668 | 285,720.00 | -17.08 | -- | -17.32 | -- | 30.00 | -- | -10,954.38 | -- | 60.62 | -- | 0.00 | -- | -97.61 | -- | 14.65 | -- | -- | -- |
Data as of Feb 10 2026. Currency figures normalised to Ribomic Inc's reporting currency: Japanese Yen JPY
0.62%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Evolution Capital Management LLCas of 10 Dec 2025 | 338.30k | 0.62% |
Data from 30 Jan 2026 - 30 Jan 2026Source: FactSet Research Systems Inc.
